Analyzing Bioterror Response Logistics: The Case of Anthrax

Published Online:https://doi.org/10.1287/mnsc.1040.0348

References

  • Alibek K. W.Biohazard (2000) (Dell Publishing Co)Google Scholar
  • Baccam S., Boechler M. Analysis of public health policies: Evaluation of impact on anthrax casualties. (2004) . Innovative Emergency Management, Inc., Baton Rouge, LAGoogle Scholar
  • Brookmeyer R., Johnson E. Computer program to evaluate public health policy options in response to an anthrax outbreak: The impact of post exposure antibiotics and vaccine. (2004) . Technical report, Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MDGoogle Scholar
  • Brookmeyer R., Johnson E., Bollinger R. Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak. Proc. National Acad. Sci. (2003) 100:10129–10132CrossrefGoogle Scholar
  • Brookmeyer R., Blades N., Hugh-Jones M., Henderson D. A. The statistical analysis of truncated data: Application to the Sverdlovsk anthrax outbreak. Biostatistics (2001) 2:233–247CrossrefGoogle Scholar
  • Flynn S. E.America the Vulnerable (2004) (HarperCollins Publishers, New York) Google Scholar
  • Gleiser C. A., Berdjis C. C., Hartman H. A., Gochenour W. S. Pathology of experimental respiratory anthrax in Macaca mulatta. British J. Experiment. Pathology (1963) 44:416–426Google Scholar
  • Gradshteyn I. S., Ryzhik I. M.Tables of Integrals, Series, and Products (1980) (Academic Press, Inc., San Diego, CA) Google Scholar
  • Guillemin J.Anthrax (1999) (University of California Press, Berkeley, CA) CrossrefGoogle Scholar
  • Hanna S. R., Briggs G. A., Hosker R. P.Handbook on Atmospheric Diffusion (1982) (U.S. Department of Energy Report DOE/TIC-11223, Washington, DC) CrossrefGoogle Scholar
  • Henderson D. A. The looming threat of bioterrorism. Science (1999) 283:1279–1282CrossrefGoogle Scholar
  • Hupert N., Mushlin A. I., Callahan M. A. Modeling the public health response to bioterrorism: Using discrete event simulation to design antibiotic distribution centers. Medical Decision Making (2002) 22:S17–CrossrefGoogle Scholar
  • Inglesby T. V., Henderson D. A., Bartlett J. G., Ascher M. S., Eitzen E., Friedlander A. M., Hauer J., McDade J., Osterholm M. T., O’Toole T., Parker G., Perl T. M., Russell P. K., Tonat K. Anthrax as a biological weapon, 2002: Updated recommendations for management. JAMA (2002) 287:2236–2252for the Working Group on Civilian BiodefenseCrossrefGoogle Scholar
  • Jernigan J. A., Stephens D. S., Ashford D. A., Omenaca C., Topiel M. S., Galbraith M., Tapper M., Fisk T. L., Zaki S., Popovic T., Meyer R. F., Quinn C. P., Harper S. A., Fridkin S. K., Sejvar J. J., Shephard C. W., McConnell M., Guarner J., Shieh W.-J., Malecki J. M., Gerberding J. L., Hughes J. M., Perkins B. A. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerging Infectious Diseases (2001) 7:933–944CrossrefGoogle Scholar
  • Kaplan E. H. Situational awareness in a spreadsheet: Estimating the size and time of a bioterror attack. Emerging Infectious Diseases (2004) 10:1202–1205CrossrefGoogle Scholar
  • Kaplan E. H., Wein L. M. Smallpox bioterror response. Science (2003) 300:1503CrossrefGoogle Scholar
  • Kaplan E. H., Craft D. L., Wein L. M. Emergency response to a smallpox attack: The case for mass vaccination. Proc. National Acad. Sci. (2002) 99:10935–10940CrossrefGoogle Scholar
  • Kaplan E. H., Craft D. L., Wein L. M. Analyzing bioterror response logistics: The case of smallpox. Math. Biosciences (2003) 185:33–72CrossrefGoogle Scholar
  • Manchee R. J., Broster M. G., Melling J., Henstridge R. M., Stagg A. J. Bacillus Anthracis on Gruinard Island. Nature (1981) 294:254–255CrossrefGoogle Scholar
  • Meselson M., Guillemin J., Hugh-Jones M., Langmuir A., Popova I., Shelokov A., Yampalskaye D. The Sverdlovsk anthrax outbreak of 1979. Science (1994) 266:1202–1208CrossrefGoogle Scholar
  • Mourez M., Kane R. S., Mogridge J., Metallo S., Deschatelets P., Sellman B. R., Whitesides G. M., Collier R. J. Designing a polyvalent inhibitor of anthrax toxin. Nature Biology (2001) 14:958–961CrossrefGoogle Scholar
  • Office of Technology Assessment, United States CongressProliferation of Weapons of Mass Destruction (1993) (U.S. Government Printing Office, Pub. OTA-ISC-559, Washington, DC) Google Scholar
  • Thompson M. W.The Killer Strain: Anthrax and a Government Exposed (2003) (HarperCollins, New York) Google Scholar
  • United States Postal Service (2004) . U.S. Postal Service may deliver medicine in the event of catastrophic incident. News release 04-015 February 18, Washington, DCGoogle Scholar
  • Webb G. F., Blaser M. J. Mailborne transmission of anthrax: Modeling and implications. Proc. National Acad. Sci. (2002) 99:7027–7032CrossrefGoogle Scholar
  • Wein L. M., Craft D. L. Evaluation of public health interventions for anthrax: A report to the Secretary’s Council on Public Health Preparedness. (2004) (Graduate School of Business, Stanford University, Stanford, CA) Google Scholar
  • Wein L. M., Kaplan E. H. Unready for anthrax. Op-Ed. Washington Post (2003) July 28):A21Google Scholar
  • Wein L. M., Craft D. L., Kaplan E. H. Emergency response to an anthrax attack. Proc. National Acad. Sci. (2003) 100:4346–4351CrossrefGoogle Scholar
  • Wein L. M., Liu Y., Leighton T. J. Evaluation of a HEPA/ vaccine plan for indoor remediation after an airborne anthrax attack. Emerging Infectious Diseases (2005) 11:69–76CrossrefGoogle Scholar
  • World Health OrganizationHealth Aspects of Chemical and Biological Weapons (1970) (Geneva, Switzerland)Google Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.